Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registry to Collect Characteristics and Outcomes From Patients With Solid Tumors Profiled With a Next-Generation Sequencing Test (WAYFIND-R)

NCT04529122 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT04529122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04529122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registry to Collect Characteristics and Outcomes From Patients With Solid Tumors Profiled With a Next-Generation Sequencing Test (WAYFIND-R)
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
August 27, 2020
Completion date
April 24, 2026
Enrollment
7,864 (actual)
Sites
136

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumours